Contains fulltext : 71029.pdf ( ) (Closed access)In a large group of patients with the clinical phenotype of familial hypercholesterolemia, such as elevated low-density lipoprotein (LDL) cholesterol and premature atherosclerosis, but without functional mutations in the genes coding for the LDL receptor and apolipoprotein B, we examined the effect of 128 seemingly neutral exonic and intronic DNA variants, discovered by routine sequencing of these genes. Two variants, G186G and R385R, were found to be associated with altered splicing. The nucleotide change leading to G186G resulted in the generation of new 3'-splice donor site in exon 4 and R385R was associated with a new 5'-splice acceptor site in exon 9 of the LDL receptor...
International audienceBACKGROUND: The LDLR (low-density lipoprotein receptor) in the liver is the ma...
Basic science research. Presentation Type: Oral presentation. Introduction: Coronary artery diseases...
A common synonymous single nucleotide polymorphism in exon 12 of the low-density lipoprotein recepto...
In a large group of patients with the clinical phenotype of familial hypercholesterolemia, such as e...
Familial hypercholesterolemia (FH) is an autosomal dominant lipoprotein disorder caused by defects i...
Familial hypercholesterolaemia (FH) is usually caused by mutations in the low density lipoprotein (L...
In this report, we describe the characterization of a mutation in the low density lipoprotein (LDL) ...
PURPOSE OF REVIEW: To review recent publications concerning the functional assessment on pre-mRNA sp...
Contains fulltext : 154823.pdf (publisher's version ) (Open Access)Through high co...
To access publisher's full text version of this article click on the hyperlink belowBackground: Loss...
Basic Science Research. Presentation type: Digital Poster. Introduction: Familial hypercholesterolem...
Item does not contain fulltextThe majority of patients with the autosomal dominant disorder familial...
Familial hypercholesterolemia (FH) results from defective low-density lipoprotein receptor (LDLR) ac...
Background and aims: Familial hypercholesterolemia (FH) is caused by pathogenic variants in LDLR, AP...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder typified by elevated low-densit...
International audienceBACKGROUND: The LDLR (low-density lipoprotein receptor) in the liver is the ma...
Basic science research. Presentation Type: Oral presentation. Introduction: Coronary artery diseases...
A common synonymous single nucleotide polymorphism in exon 12 of the low-density lipoprotein recepto...
In a large group of patients with the clinical phenotype of familial hypercholesterolemia, such as e...
Familial hypercholesterolemia (FH) is an autosomal dominant lipoprotein disorder caused by defects i...
Familial hypercholesterolaemia (FH) is usually caused by mutations in the low density lipoprotein (L...
In this report, we describe the characterization of a mutation in the low density lipoprotein (LDL) ...
PURPOSE OF REVIEW: To review recent publications concerning the functional assessment on pre-mRNA sp...
Contains fulltext : 154823.pdf (publisher's version ) (Open Access)Through high co...
To access publisher's full text version of this article click on the hyperlink belowBackground: Loss...
Basic Science Research. Presentation type: Digital Poster. Introduction: Familial hypercholesterolem...
Item does not contain fulltextThe majority of patients with the autosomal dominant disorder familial...
Familial hypercholesterolemia (FH) results from defective low-density lipoprotein receptor (LDLR) ac...
Background and aims: Familial hypercholesterolemia (FH) is caused by pathogenic variants in LDLR, AP...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder typified by elevated low-densit...
International audienceBACKGROUND: The LDLR (low-density lipoprotein receptor) in the liver is the ma...
Basic science research. Presentation Type: Oral presentation. Introduction: Coronary artery diseases...
A common synonymous single nucleotide polymorphism in exon 12 of the low-density lipoprotein recepto...